NorCal Endocrinology and Internal Medicine
San Ramon, California, United States
Endocrinologist in San Ramon, California
111 Deerwood Rd STE 180, San Ramon, CA 94583
About NorCal Endocrinology and Internal Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Boehringer Ingelheim
1
Mylan Inc.
1
Clinical Trials at NorCal Endocrinology and Internal Medicine
During the past decade, NorCal Endocrinology and Internal Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus
2015-10-20
2017-05-09
Completed
420
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
2015-12-22
2017-09-20
Completed
977
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "NorCal Endocrinology and Internal Medicine"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at NorCal Endocrinology and Internal Medicine
According to Clinical.Site data, the most researched conditions in "NorCal Endocrinology and Internal Medicine" are
"Diabetes Mellitus, Type 1" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "NorCal Endocrinology and Internal Medicine" in a lesser frequency.
Clinical Trials Intervention Types at NorCal Endocrinology and Internal Medicine
Most popular intervention types in "NorCal Endocrinology and Internal Medicine" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Dulaglutide" (1 trials), "Empagliflozin" (1 trials), "FlexPen NovoLog®" (1 trials), "Human regular U-500 insulin (CSII)" (1 trials) and "Human regular U-500 insulin (MDI)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NorCal Endocrinology and Internal Medicine
The vast majority of trials in "NorCal Endocrinology and Internal Medicine" are
4 trials for "All" genders.
Clinical Trials Status at NorCal Endocrinology and Internal Medicine
Currently, there are NaN active trials in "NorCal Endocrinology and Internal Medicine".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in NorCal Endocrinology and Internal Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NorCal Endocrinology and Internal Medicine, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".